Copyright
©The Author(s) 2024.
World J Gastroenterol. Nov 21, 2024; 30(43): 4609-4619
Published online Nov 21, 2024. doi: 10.3748/wjg.v30.i43.4609
Published online Nov 21, 2024. doi: 10.3748/wjg.v30.i43.4609
Figure 1 SHOX2, RNF180, and EPO expression and methylation in normal esophageal tissue (n = 11) and esophageal cancer tissue (n = 181) samples from previously reported genome data.
A, C, and E: Expression of SHOX2, RNF180, and EPO was up- or downregulated in esophageal cancer (EC) tissues (n = 181); B, D, and F: Promoter methylation levels of SHOX2, RNF180, and EPO in normal esophageal tissues (n = 11) and EC tissues (n = 181), as indicated by beta values ranging from 0 (unmethylated) to 1 (fully methylated). aP < 0.05. EC: Esophageal cancer.
- Citation: Liu XJ, Pi GL, Wang S, Kai JD, Yu HF, Shi HW, Yu J, Zeng H. Plasma DNA methylation detection for early screening, diagnosis, and monitoring of esophageal adenocarcinoma and squamous cell carcinoma. World J Gastroenterol 2024; 30(43): 4609-4619
- URL: https://www.wjgnet.com/1007-9327/full/v30/i43/4609.htm
- DOI: https://dx.doi.org/10.3748/wjg.v30.i43.4609